Beijing Biostar Pharmaceuticals Co., Ltd. - Audit Report / Information 2023

dcsimg

PHIP



	Beijing Biostar Pharmaceuticals Co., Ltd.- B

	YOU SHOULD READ THE WARNING IN THE DOCUMENT.


►	WARNING
►	IMPORTANT
►	EXPECTED TIMETABLE
►	CONTENTS
►	SUMMARY
►	DEFINITIONS
►	GLOSSARY OF TECHNICAL TERMS
►	FORWARD-LOOKING STATEMENTS
►	RISK FACTORS
►	WAIVERS FROM STRICT COMPLIANCE WITH THE LISTING RULES AND EXEMPTION FROM STRICT COMPLIANCE WITH THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE
►	INFORMATION ABOUT THIS DOCUMENT AND THE [REDACTED]
►	DIRECTORS, SUPERVISORS AND PARTIES INVOLVED IN THE [REDACTED]
►	CORPORATE INFORMATION
►	INDUSTRY OVERVIEW
►	REGULATORY OVERVIEW
►	HISTORY, DEVELOPMENT AND CORPORATE STRUCTURE
►	BUSINESS
►	DIRECTORS, SUPERVISORS AND SENIOR MANAGEMENT
►	RELATIONSHIP WITH OUR SINGLE LARGEST GROUP OF SHAREHOLDERS
►	SUBSTANTIAL SHAREHOLDERS
►	SHARE CAPITAL
►	[REDACTED]
►	FINANCIAL INFORMATION
►	FUTURE PLANS AND [REDACTED]
►	[REDACTED]
►	STRUCTURE OF THE [REDACTED]
►	HOW TO APPLY FOR [REDACTED]
►	APPENDIX I - ACCOUNTANTS' REPORT
►	APPENDIX II - UNAUDITED [REDACTED] FINANCIAL INFORMATION
►	APPENDIX III - PROPERTY VALUATION REPORT
►	APPENDIX IV - TAXATION AND FOREIGN EXCHANGE
►	APPENDIX V - SUMMARY OF PRINCIPAL LEGAL AND REGULATORY PROVISIONS
►	APPENDIX VI - SUMMARY OF ARTICLES OF ASSOCIATION
►	APPENDIX VII - STATUTORY AND GENERAL INFORMATION
►	APPENDIX VIII - DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES IN HONG KONG AND AVAILABLE ON DISPLAY

AI assistant